249 results on '"Hruskova, Zdenka"'
Search Results
2. A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis
3. Extrarenal complications of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) and their impact on the outcome of the patients
4. Granulomatosis with polyangiitis mimicking cancer: a diagnostic dilemma
5. Long-term outcome of kidney function in patients with ANCA-associated vasculitis.
6. WCN24-815 THE EFFECTS OF HEMODIALYSIS FISTULA FLOW ON THE RIGHT HEART AND ON PULMONARY HYPERTENSION
7. WCN24-871 HIGH-OUTPUT HEART FAILURE AMONG PATIENTS ON CHRONIC HEMODIALYSIS: NOT ONLY DUE TO HIGH FISTULA FLOW
8. WCN24-2509 RETROSPECTIVE HISTOPATHOLOGICAL ANALYSIS OF FIBRILLARY GLOMERULONEPHRITIS
9. Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis
10. WCN24-2506 IMMUNOSUPPRESSIVE THERAPY IS NOT ASSOCIATED WITH INCREASED FREQUENCY OF PERITONITIS IN PERITONEAL DIALYSIS PATIENTS – A SINGLE CENTRE EXPERIENCE
11. Rituximab in Membranous Nephropathy
12. Mass spectrometry-based proteomic exploration of the small urinary extracellular vesicles in ANCA-associated vasculitis in comparison with total urine
13. Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers’ perspective
14. AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats
15. Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?
16. Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying
17. Echocardiography in patients with chronic kidney diseases
18. Heart failure with preserved ejection fraction is the most frequent but commonly overlooked phenotype in patients on chronic hemodialysis
19. Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspective.
20. Data quality and patient characteristics in European ANCA- associated vasculitis registries: data retrieval by federated querying.
21. CZecking heart failure in patients with advanced chronic kidney disease (Czech HF-CKD): Study protocol.
22. Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA – associated vasculitis
23. Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study
24. Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction:a multicentre study
25. The frequency of, and predisposing risk factors for, ciprofloxacin-induced neuro-psychiatric adverse drug reactions.
26. Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
27. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association–European Dialysis and Transplant Association Registry
28. Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study
29. Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives
30. Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis.
31. Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy.
32. Rituximab for treatment of severe renal disease in ANCA associated vasculitis
33. Complement Inhibition in ANCA-Associated Vasculitis
34. CZecking heart failure in patients with advanced chronic kidney disease (Czech HF-CKD): Study protocol
35. Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis
36. Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus:Findings From the ERA Registry
37. Analysis of microRNAs in Small Urinary Extracellular Vesicles and Their Potential Roles in Pathogenesis of Renal ANCA-Associated Vasculitis
38. sj-pdf-1-jva-10.1177_11297298221099843 – Supplemental material for CZecking heart failure in patients with advanced chronic kidney disease (Czech HF-CKD): Study protocol
39. ANCA Vasculitis Induction Management During the COVID-19 Pandemic
40. Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry
41. Granulomatosis with polyangiitis mimicking cancer: a diagnostic dilemma
42. Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis
43. Reduction of arteriovenous access blood flow leads to biventricular unloading in haemodialysis patients
44. FC 033LONG-TERM FOLLOW-UP OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIS INCLUDED IN EUROPEAN VASCULITIS SOCIETY RANDOMIZED CLINICAL TRIALS SINCE 1995: A SURVIVAL ANALYSIS
45. Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis
46. The effect of high‐flow arteriovenous fistulas on systemic haemodynamics and brain oxygenation
47. Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy
48. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
49. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status
50. Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.